(A) GFP expression in mature Fo splenic B cells (CD19+CD23+CD93-) from Nur77-eGFP BAC Tg reporter mice with either a wild-type BCR repertoire (left), or harboring IgHEL Tg specific for the cognate …
Numerical data corresponding to receptor and Nur77 reporter, protein and transcript levels in Figure 1D–F and Figure 1—figure supplement 1D-G, 2B-E.
Numerical data corresponding to receptor and Nur77-eGFP levels in Figure 1D Source code used to calculate median Igκ for given levels of Nur77-eGFP in Figure 1F. Numerical data corresponding to endogenous Nur77 in germ-free mice depicted in Figure 1—figure supplement 1D. Numerical data corresponding to Nr4a1 transcript in germ-free mice depicted in Figure 1—figure supplement 1E. Numerical data corresponding to endogenous Nur77 in MyD88-conditional-knockout peritoneal B1a cells in Figure 1—figure supplement 1F. Numerical data corresponding to Nr4a1 transcript in MyD88-conditional-knockout splenocytes in Figure 1—figure supplement 1G. Numerical data corresponding to surface BCR levels on splenic B cells subsets in Figure 1—figure supplement 2B–C. Numerical data corresponding to surface BCR levels on peritoneal B cell subsets in Figure 1—figure supplement 2D–E.
Numerical data corresponding to receptor levels in Figure 1D.
Numerical data corresponding to Nur77-eGFP levels in Figure 1E.
(A) Nur77-eGFP expression in mature Fo (B220+CD93-CD23+) B cells from mice with mutations in various signaling pathways (CD40L−/−, Unc93b13d/3d,TLR7−/−). This Unc93b1 mutation abolishes signaling …
(A) Surface Igκ expression relative to Nur77-eGFP reporter in Fo B cells from WT, IgM−/−, and IgD−/− mice. (B) Mean surface Igκ expression was calculated for Igκ+ splenic B cell (B220+) subsets in …
(A) Nur77-eGFP and CD69 upregulation in IgM−/− and IgD−/− splenic B cells stimulated with indicated doses of LPS, CpG, and Pam3CSK4. Histograms compare unstimulated cells with cells incubated with …
(A) Median intracellular pErk in splenic CD23+ B cells stimulated with anti-Igκ for 15 min. (B) Erk phosphorylation kinetics in splenic CD23+ B cells stimulated with 15 μg/mL anti-Igκ. (C) …
Numerical data corresponding to Figure 2A and B, E-I, and Figure 2—figure supplement 1A.
Numerical data corresponding to ERK phosphorylation in Figure 2A–B. Numerical data corresponding to activation marker upregulation in Figure 2E–H. Numerical data corresponding to basal calcium in Figure 2I. Numerical data corresponding to S6 phosphorylation in Figure 2—figure supplement 1A.
Numerical data corresponding to basal calcium in Figure 2I.
(A) S6 phosphorylation kinetics in splenic CD23+ B cells following stimulation with 15 μg/mL anti-Igκ. (B) Splenocytes from IgM−/− and IgD−/− mice were loaded with Indo-1 and stimulated with 10 or 5 …
(A) Nur77-eGFP in peritoneal B1a (CD19+CD5+CD23-) and splenic MZ (B220+CD21hiCD23lo) B cells from WT and IgM−/− mice. (B) Nur77-eGFP in PtC-binding peritoneal B1a cells from WT, IgM−/−, and IgD−/− …
Numerical data corresponding to Nur77-eGFP and BCR expression in innate-like B cells in Figures 3A, C, E, Figure 3—figure supplement 1A-C.
Numerical data corresponding to Nur77-eGFP expression and PtC binding in B1a cells in Figure 3A and C. Numerical data corresponding to Nur77-eGFP and surface receptor levels in BaffTg+ MZ B cells in Figure 3E and Figure 3—figure supplement 1A. Numerical data corresponding to Nur77-eGFP expression in innate-like B cells in Figure 3—figure supplement 1B. Numerical data corresponding to Nur77-eGFP expression in MZ B cells in Figure 3—figure supplement 1C.
Numerical data corresponding to Nur77-eGFP expression and PtC binding in B1a cells in Figure 3C.
(A) Surface Igκ MFI of IgM−/− and IgD−/− splenic MZ B cells from mice without (left) and with (right) a BAFF overexpression transgene. (B) Nur77-eGFP expression in peritoneal B1a and splenic MZ B …
(A) Allelic exclusion leads to a 1:1 mixture of IgM-only and IgD-only B cells in IgM+/− IgD−/+ mice. (B) Proportion of peritoneal B1a (CD19+CD5+CD23-) and splenic MZ (B220+CD21hiCD23lo) B cells …
Numerical data corresponding to competition between IgM-only, IgD-only and WT B cells in Figure 4B–F, and in Figure 4—figure supplement 1B-D
Numerical data corresponding to competition between IgM-only, IgD-only and WT B cells inFigures 4B-F.Numerical data corresponding to splenic and peritoneal B cell compartment sizes in Figure 4—figure supplement 1B–C. Numerical data corresponding to competition between IgHa and IgHb B cells in Figure 4—figure supplement 1D.
Numerical data corresponding to competition between IgM-only, IgD-only and WT B cells in Figure 4B–E.
Numerical data corresponding to competition between IgD-only and WT B cells in Figure 4F.
(A) Signal strength model of B1a and MZ B cell development. While B1a and MZ cells originate from different precursor populations, their development is thought to be BCR signal strength-dependent. (B…
(A) Surface CD69 and CD86 expression on CD23+ splenic B cells from each Ig locus in IgM+/− mice on Lyn+/+ and Lyn−/− backgrounds. (B) Percentage of unswitched germinal center (CD19+ Fashi GL-7hi …
Numerical data corresponding to Figure 5A-G,Figure 5—figure supplement 1B-C, 3C-E.
Numerical data corresponding to germinal center composition in Figure 5B. Numerical data corresponding to autoantibody production in Figure 5C–G. Numerical data corresponding to cellular phenotypes of IgHa/b Lyn−/− mice in Figure 5—figure supplement 1A–B and Figure 5—figure supplement 3C. Numerical data corresponding to follicular B cell competition in Lyn-deficient IgM+/− and IgD+/− mice in Figure 5—figure supplement 1C. Numerical data corresponding to germinal center composition in Figure 5—figure supplement 3B-C. Numerical data corresponding to autoantibody production in Figure 5—figure supplement 3D–E.
(A) Gating scheme for determining Ig locus of origin for splenic B cell subsets in 6-month-old IgHa/b Lyn−/− mice. (B) Quantification of compartments in (A). T1 (CD93+CD23-); T2/3 (CD93+CD23+); Fo …
(A) Splenocytes from IgM+/− and IgD+/− mice on either Lyn+/+ or Lyn−/− backgrounds were loaded with Indo-1 and stimulated with anti-Igκ. WT (IgMb+) B cells were gated out to isolate IgM-null …
(A) Nur77-eGFP expression in splenic mature Fo B cells from Lyn+/+ and Lyn−/− reporter mice. (B) Gating scheme for determining the Ig locus of origin for germinal center B cells in 6-month-old IgM+/−…
(A) Representative blot and quantification of Ets1 and GAPDH protein in purified splenic B cells from WT, Lyn−/−, and IgM−/− Lyn−/− mice. (B) Composition of the CD138+ plasma cell compartments in …
Numerical data corresponding to Ets1 expression, plasma cell compartments, and serum IgM and IgD titers in Figure 6A-G.
Numerical data corresponding to Ets1 expression in Figure 6A. Numerical data corresponding to plasma cell compartments in Figure 6B–C. Numerical data corresponding to serum IgM titers in Figure 6D. Numerical data corresponding to serum IgD titers in Figure 6E. - Numerical data corresponding to plasma cell competition in Figure 6F and G.
Numerical data corresponding to Ets1 expression in splenic B cells in Figure 6A.
Numerical data corresponding to plasma cell compartments in Figure 6B–C.
(A) Intracellular Erk phosphorylation in peritoneal B220+ B cells stimulated with anti-Igκ for 5 min. B1a (CD5+CD23-); B2 (CD5-CD23+). Histograms in (A) are representative of cells from n = 2 WT and …
(A) Model: Lyn restrains BCR signaling in Fo B cells. Loss of Lyn leads to Btk-dependent downregulation of Ets1 expression and consequent expansion of unswitched (IgM+) plasma cells.
(A) Splenic (CD19+) B cells from WT, IgM−/−, and IgD−/− mice unimmunized or 5 days after i.p. immunization with 200 μL of 10% SRBCs. (B) Quantification of germinal center (Fashi GL-7hi) cells in (A).…
Numerical data corresponding to germinal center and plasma cell responses in Figure 7B-I,Figure 7—figure supplement 1A–D
Numerical data corresponding to germinal center and plasma cell responses in Figure 7B-I, Figure 7—figure supplement 1A–B. Numerical data corresponding to unswitched plasma cell responses in Figure 7—figure supplement 1C–D.
(A) Quantification of IgMa+ and IgMb+ germinal center B cells (CD19+FashiGL-7hi) as a percentage of live splenocytes in IgHa/b mice 5 days after i.p. immunization with 200 μL of 10% SRBCs. (B) …
(A) Model: Control of peripheral B cell tolerance by IgM and IgD. Selective downregulation of IgM is a well-described feature of autoreactive B cells. This study demonstrates how loss of IgM could …
Panel (A) take from Manuscript Figure 1A. Panel (B) depicts quantification of mean Nur77-eGFP MFI -/- SEM in N=5 biological replicates.
BM and splenic B cells from our Nur77-eGFP reporter mice (Zikherman et al., 2012) as well as independent reporter line (Moran et al. JEM 2011) were stimulated in vitro with media alone (shaded gray …
Nur77-eGFP BAC Tg was crossed to the Vh3H9 HC site directed Tg. BM and splenic cells from these mice (red) and unrestricted repertoire reporter mice (gray) were harvested and stained ex vivo to …
(A) Intracellular staining of endogenous Nur77 protein in splenic B cells from Nr4a1+/+, -/-, and -/- mice. Graph depicts mean -/- SEM of N=3 mice / genotype. (B) Nur77-eGFP reporter B cells were …
Splenocytes from MyD88 cKO or control mice were stimulated for 2 hours with LPS (333 ng/ml). Graph depicts mean MFI of Intracellular staining to detect Nur77 upregulation in splenic B cells -/- SEM …
Splenocytes from non-BCR Tg and IgHEL BCR Tg reporter mice were stimulated overnight with low and high doses of ligands for TLR4 / rp105 (A), TLR9 (B), and TLRs1/2 (C). Histograms depict GFP …
Splenocytes from IgM-/-, IgD-/-, or WT ice were stained to detect surface expression of CD19, CD22, CD45, CD79b, and kappa light chain. Histograms depict CD23+ splenocyte gate. Differences in …
(A) Plots show CD19+ PerC cells gated to identify CD5+ B1a cells (reduced in IgM-/- as shown in Figure 4—figure supplement 1). Histograms depict CD5 and CD19 expression in B1a cells. (B) Plots show …
(Figure 2A,B reproduced from Figure 2 of Huizar et al., 2017, Immunohorizons, published under the Creative Commons Attribution 4.0 International Public License (CC BY4.0; …
Representative western blot of splenic B cells probed for Ets1 on left. Graph depicts mean normalized protein expression -/- SEM of N=3 biological replicates.
Conclusion | Stimulus/perturbation | Pathway | Readout | Cell type | References |
---|---|---|---|---|---|
Does not modulate Nur77 at steady state in vivo | CD40L-/- | CD40 | Nur77-eGFP | B cells | Manuscript Figure 1—figure supplement 1A |
TLR7-/- | TLR7 | Nur77-eGFP | B cells | Manuscript Figure 1—figure supplement 1A | |
Un93b13d/3d | TLR3/7/9 | Nur77-eGFP | B cells | Manuscript Figure 1—figure supplement 1A | |
MyD88fl/fl MB1-Cre | MyD88 | Endog. Nur77 protein/transcript | PerC B1a cells/spleen | Manuscript Figure 1—figure supplement 1F,G | |
Germ-free mice | MyD88/TRIF | Endog. Nur77 protein/transcript | Splenic B cells/spleen | Manuscript Figure 1—figure supplement 1D,E | |
Const. act. STAT5 | Jak/Stat | Nur77-eGFP | Thymocytes | Moran et al. JEM 2011, Figure 8. | |
Does not induce Nur77 in vitro | BAFF | BAFFR | Nur77-eGFP | B cells | Zikherman et al. (2012): Figure S1G |
IL-4 | Jak/Stat | Nur77-eGFP | B cells | Manuscript Figure 1—figure supplement 1B | |
IL-2, IL-15 | Jak/Stat | Nur77-eGFP | CD8 (IL-2, 15), CD4 (IL-2) | Au-Yeung et al. JI 2017, Figures S1A, 3C, 4A | |
CXCL12/ SDF-1 | CXCR4 | Nur77-eGFP | B cells | Manuscript Figure 1—figure supplement 1C | |
Induces Nur77 in vitro but does not require IgM or IgD specifically | LPS | TLR4, Rp150 | Nur77-eGFP | B cells | Zikherman et al. (2012): Figure S1G; Manuscript Figure 1—figure supplement 3A |
CpG | TLR9 | Nur77-eGFP | B cells | Zikherman et al. (2012), Figure S1G; Manuscript Figure 1—figure supplement 3A | |
Pam3CSK4 | TLR1/2 | Nur77-eGFP | B cells | Manuscript Figure 1—figure supplement 3A | |
Anti-Igκ | BCR | Nur77-eGFP | B cells | Manuscript Figure 2F | |
Modulates pathway at steady state in vivo | IgHEL Tg | Antigen/BCR | Nur77-eGFP | B cells | Zikherman et al. (2012), Figure 3B,C; Manuscript Figure 1A |
IgHEL BCR Tg/sHEL Ag | Antigen/BCR | Nur77-eGFP | B cells | Zikherman et al. (2012), Figure 3B,C; Manuscript Figure 1A | |
Lyn-/- | BCR via ITIMs | Nur77-eGFP | B cells | Manuscript Figure 5—figure supplement 3A | |
CD45 allelic series | BCR via SFKs | Nur77-eGFP | B cells | Zikherman et al. (2012), Figure 3A,B |
Reagent type (species) or resource | Designation | Source or reference | Identifiers | Additional information |
---|---|---|---|---|
Strain, strain background (Mus musculus) | C56BL/6 | The Jackson Laboratory; Taconic | JAX:000664; TAC:BCNTac | |
Strain, strain background (M. musculus) | Balb/C | The Jackson Laboratory | JAX:000651 | |
Strain, strain background (M. musculus) | Nur77-eGFP | MMRRC UC Davis | MMRRC:012015-UCD | Characterized in PMID:22902503 |
Strain, strain background (M. musculus) | IgHEL | PMID:3261841 | MD-4 | |
Strain, strain background (M. musculus) | sHEL | PMID:3261841 | ML-5 | |
Strain, strain background (M. musculus) | IgM-/- | PMID:9655395 | ||
Strain, strain background (M. musculus) | IgD-/- | PMID:8446604 | ||
Strain, strain background (M. musculus) | CD40L-/- | PMID:7964465 | ||
Strain, strain background (M. musculus) | Unc93b 3d/3d | PMID:16415873 | ||
Strain, strain background (M. musculus) | TLR7-/- | PMID:15034168 | ||
Strain, strain background (M. musculus) | BaffTg | MMRRC UC Davis | RRID:MMRRC_036508-UCD | Described in PMID:15972664 |
Strain, strain background (M. musculus) | B6.IgHa | The Jackson Laboratory | JAX:001317 | B6.Cg-Gpi1a Thy1a Igha/J |
Strain, strain background (M. musculus) | Lyn-/- | PMID:9252121 | ||
Strain, strain background (M. musculus) | MB1-Cre | PMID:16940357 | ||
Strain, strain background (M. musculus) | MyD88 fl/fl | PMCID:PMC2847796 | ||
Strain, strain background (M. musculus) | Nr4a1-/- | PMID:7624775 | JAX:006187 | |
Biological sample (Ovis aires) | Sheep Red Blood Cells | Rockland | R406-0050 | |
Antibody | Anti-B220-A647 (rat monoclonal) | BD Pharmingen | 557683 | (1:200) |
Antibody | Anti-B220-APC-e780 (rat monoclonal) | eBioscience | 47-0452-82 | (1:400) |
Antibody | Anti-B220-FITC (rat monoclonal) | Tonbo | 35–0452 U100 | (1:200) |
Antibody | Anti-B220-Pacific Blue (rat monoclonal) | Tonbo | 75–0452 U100 | (1:200) |
Antibody | Anti-B220-PE (rat monoclonal) | BD Pharmingen | 553090 | (1:200) |
Antibody | Anti-B220-PE-Cy7 (rat monoclonal) | BD Pharmingen | 552772 | (1:200) |
Antibody | Anti-B220-PerCP-Cy5.5 (rat monoclonal) | Tonbo | 65–0452 U100 | (1:200) |
Antibody | Anti-CD5-APC (rat monoclonal) | Tonbo | 20–0051 U100 | (1:100) |
Antibody | Anti-CD19-PE-Cy7 (rat monoclonal) | Biolegend | 115520 | (1:150) |
Antibody | Anti-CD19-PerCP-Cy5.5 (rat monoclonal) | BD Pharmingen | 551001 | (1:150) |
Antibody | Anti-CD21-A647 (rat monoclonal) | Biolegend | 123424 | (1:100) |
Antibody | Anti-CD21-Pacific Blue (rat monoclonal) | Biolegend | 123414 | (1:100) |
Antibody | Anti-CD23-A647 (rat monoclonal) | Biolegend | 101612 | (1:200) |
Antibody | Anti-CD23-FITC (rat monoclonal) | BD Pharmingen | 553138 | (1:200) |
Antibody | Anti-CD23-Pacific Blue (rat monoclonal) | Biolegend | 101616 | (1:100) |
Antibody | Anti-CD23-PE (rat monoclonal) | BD Pharmingen | 553139 | (1:200) |
Antibody | Anti-CD23-PE-Cy7 (rat monoclonal) | eBioscience | 25-0232-82 | (1:200) |
Antibody | Anti-CD69-APC (hamster monoclonal) | Biolegend | 104514 | (1:100) |
Antibody | Anti-CD69-PE-Cy7 (hamster monoclonal) | Tonbo | 60–0691 U100 | (1:100) |
Antibody | Anti-CD86-Pacific Blue (rat monoclonal) | Biolegend | 105022 | (1:100) |
Antibody | Anti-CD93 (AA4.1)-PE-Cy7 (rat monoclonal) | Biolegend | 136506 | (1:100 |
Antibody | Anti-CD138-PE (rat monoclonal) | Biolegend | 142504 | (1:100) |
Antibody | Anti-CD138-PE-Cy7 (rat monoclonal) | Biolegend | 142513 | (1:100) |
Antibody | Anti-CXCR4-Biotin (rat monoclonal) | BD Pharmingen | 551968 | (1:100) |
Antibody | Anti-ETS1 (rabbit monoclonal) | Epitomics; abcam | EPI:3123–1; AB:109212 | (1:10,000); concentrated lot from L.A. Garrett-Sinha |
Antibody | Anti-Fas-PE-Cy7 (hamster monoclonal) | BD Pharmingen | 557653 | (1:200) |
Antibody | Anti-GAPDH (mouse monoclonal) | EMD Millipore | AB2302 | (1:2000) |
Antibody | GL-7-A647 (rat monoclonal) | BD Biosciences | 561529 | (1:400) |
Antibody | Anti-IgA-Biotin (rat monoclonal) | Biolegend | 407003 | (1:400) |
Antibody | Anti-IgD (goat polyclonal serum) | MD Biosciences | 2057001 | (1:50-1:400) |
Antibody | Anti-IgD[a]-Biotin (mouse monoclonal) | BD Pharmingen | 553506 | (1:300) |
Antibody | Anti-IgD-APC-e780 (rat monoclonal) | eBioscience | 47-5993-80 | (1:500) |
Antibody | Anti-IgD-HRP (rat monoclonal) | American Research Products | 09-1008-4 | (1:2000) |
Antibody | Anti-IgD-Pacific Blue (rat monoclonal) | Biolegend | 405712 | (1:300) |
Antibody | Anti-IgD-PE (rat monoclonal) | eBioscience | 12-5993-82 | (1:800) |
Antibody | Anti-IgG1[a]-Biotin (mouse monoclonal) | BD Pharmingen | 553500 | (1:300) |
Antibody | Anti-IgG1[b]-Biotin (mouse monoclonal) | BD Pharmingen | 553533 | (1:300) |
Antibody | Anti-IgG2a[a]-Biotin (mouse monoclonal) | BD Biosciences | 553502 | (1:1000) |
Antibody | Anti-IgG2a[b]-Biotin (mouse monoclonal) | BD Biosciences | 553504 | (1:1000) |
Antibody | Anti-IgG2c-Biotin (goat polyclonal) | SouthernBiotech | 1079–08 | (1:1000) |
Antibody | Anti-Igκ (goat polyclonal) | SouthernBiotech | 1050–01 | 1–20 μg/mL |
Antibody | Anti-Igκ-F(ab')2 (goat polyclonal) | SouthernBiotech | 1052–01 | 1–20 μg/mL |
Antibody | Anti-Igκ-FITC (goat polyclonal) | SouthernBiotech | 1050–02 | (1:300) |
Antibody | Anti-Igκ-FITC (rat monoclonal) | BD Pharmingen | 550003 | (1:300) |
Antibody | Anti-Igk-PerCP-Cy5.5 (rat monoclonal) | BD Pharmingen | 560668 | (1:300) |
Antibody | Anti-Igλ-FITC (rat monoclonal) | BD Pharmingen | 553434 | (1:300) |
Antibody | Anti-Igλ-PE (rat monoclonal) | Biolegend | 407307 | (1:300) |
Antibody | Anti-IgM-F(ab')2 (goat polyclonal) | Jackson ImmunoResearch | 115-006-020 | 1–20 μg/mL |
Antibody | Anti-IgM-HRP (goat polyclonal) | SouthernBiotech | 1020–05 | (1:2000); secondary for ELISA |
Antibody | Anti-IgM[a]-Biotin (mouse monoclonal) | Biolegend | 408603 | (1:100) |
Antibody | Anti-IgM[a]-FITC (mouse monoclonal) | Biolegend | 408606 | (1:100); (1:400) for plasma cell |
Antibody | Anti-IgM[a]-PE (mouse monoclonal) | BD Pharmingen | 553517 | (1:100); (1:400) for plasma cell |
Antibody | Anti-IgM[b]-Biotin (mouse monoclonal) | Biolegend | 406204 | (1:100) |
Antibody | Anti-IgM[b]-PE (mouse monoclonal) | Biolegend | 406208 | (1:100); (1:400) for plasma cell |
Antibody | Anti-IgM-APC (rat monoclonal) | eBioscience | 17-5790-82 | (1:100) |
Antibody | Anti-MHC-2-APC (rat monoclonal) | Tonbo | 20–5321 U100 | (1:1000) |
Antibody | Anti-Mouse-IgG(H + L)-HRP (goat polyclonal) | SouthernBiotech | 1031–05 | (1:5000); secondary for western blots |
Antibody | Anti-Nur77-PE (mouse monoclonal) | eBioscience | 12-5965-80 | (1:100) |
Antibody | Anti-pERK (rabbit monoclonal) | Cell Signaling Technology | 4377S | (1:80) |
Antibody | Anti-pS6 (rabbit monoclonal) | Cell Signaling Technology | 4856S | (1:100) |
Antibody | Anti-Rabbit-IgG-APC (donkey polyclonal) | Jackson ImmunoResearch | 711-136-152 | (1:100); secondary for pERK/pS6 |
Antibody | Anti-Rabbit-IgG(H + L)-HRP (goat polyclonal) | SouthernBiotech | 4050–05 | (1:5000); secondary for western blots |
Sequence-based reagent | Nr4a1 forward primer | Elim Biopharm | gcctagcactgccaaattg | |
Sequence-based reagent | Nr4a1 reverse primer | Elim Biopharm | ggaaccagagagcaagtcat | |
Sequence-based reagent | GAPDH forward primer | Elim Biopharm | aggtcggtgtgaacggatttg | |
Sequence-based reagent | GAPDH reverse primer | Elim Biopharm | tgtagaccatgtagttgaggtca | |
Peptide, recombinant protein | NP-RSA | Biosearch | N-5054–100 | Conj. ratio: 10 |
Peptide, recombinant protein | NP-BSA | Biosearch | N-5050H-100 | Conj. ratio: 23 |
Peptide, recombinant protein | Streptavidin-HRP | SouthernBiotech | 7100–05 | (1:5000) |
Peptide, recombinant protein | Streptavidin-APC | Tonbo | 20–4317 U500 | (1:100-1:400) |
Peptide, recombinant protein | Streptavidin-Pacific Blue | Life Technologies | S11222 | (1:200) |
Peptide, recombinant protein | Streptavidin-PerCP-Cy5.5 | BD Pharmingen | 551419 | (1:400) |
Peptide, recombinant protein | Streptavidin-FITC | Biolegend | 405202 | (1:100-1:200) |
Peptide, recombinant protein | CXCL12 | Peprotech | 300-28A | |
Peptide, recombinant protein | NP-PE | Biosearch | N-5070–1 | (1:400) |
Chemical compound, drug | Poly-L-Lysine | Sigma | P2636-100MG | 100 μg/mL in 0.1 M Tris-HCl pH7.3 |
Chemical compound, drug | Poly dA-dT | Sigma | P0883-50UN | 0.2 U/mL in 0.1 M Tris-HCl pH7.3 |
Chemical compound, drug | LPS | Sigma | L8274 | |
Chemical compound, drug | CpG | InvivoGen | tlrl-1826b | |
Chemical compound, drug | Pam3CSK4 | InvivoGen | tlrl-pms | |
Commercial assay, kit | Indo-1, AM | Life Technologies | I-1223 | (1:1000) |
Commercial assay, kit | Live/Dead Fixable Near-IR Dead Cell Stain Kit | Invitrogen | L10119 | (1:1000) |
Commercial assay, kit | ECL Luminol; Oxidizer Reagents | Perkin Elmer | 0RT2751; 0RT2651 | |
Commercial assay, kit | 3,3',5,5'-Tetramethylbenzidine, Slow Kinetic Form | Sigma | T4319-100ML | ELISA substrate |
Software, algorithm | FlowJo | FlowJo LLC | Version 9.9.4 | |
Software, algorithm | Prism | GraphPad | Version 7.0b | |
Software, algorithm | Canopy | Enthought | Version 1.4.1.1975 | |
Software, algorithm | Binning program in Figure 1F | Other | Source code provided in this publication | |
Other | BD Microtainer Capillary Blood Collector | Fisher | 365967 | |
Other | PtC-Rhodamine (DOPC/CHOL Liposomes) | FormuMax | F60103F-R | (1:1000); used in PtC-specific B1a staining |
Other | NuPAGE 4–12% Bis-Tris Protein Gels | Invitrogen | NP0335BOX | |
Other | Immobilon-P PVDF Membrane | EMD Millipore | IPVH00010 | |
Other | Assay Plate, 96 Well, No Lid, Vinyl | Costar | 2595 | Used for ELISA |